US Patent 8575426 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
Patent 8575426 was granted and assigned to Novozymes on November, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08575426 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same US Patent 8575426 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
Infobox
Patent Number
0857542600
Patent Number
857542600
Edits on 23 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
0
Patent Jurisdiction
Patent Number
085754260
Date of Patent
November 5, 2013
0Patent Application Number
127460030
Date Filed
December 17, 2008
0Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
0
Patent Jurisdiction
Patent Number
085754260
Date of Patent
November 5, 2013
0Patent Application Number
127460030
Date Filed
December 17, 2008
0Patent Primary Examiner
Edits on 18 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08575426 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08575426
Date of patent
November 5, 2013
Patent application number
12746003
Date Filed
December 17, 2008
Patent primary examiner
Find more entities like US Patent 8575426 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
